Delivery Order SPE2DB25D2207-SPE2DB25FQRAG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Airsupra 90-80 microgram inhalers (10.7 grams) with a ceiling value of $3,441.57. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $14,808.52 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Airsupra 90-80 microgram inhaler units (10.7 grams). This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $3,734.64 delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 mcg inhalator (10.7gm) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded contract with firm fixed pricing carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,476.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG inhalers (10.7GM) on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $1,867.32 for AirSupra 90-80 microgram inhalant in 10.7-gram units. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded, and carries an ultimate completion date of September 30, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Airsupra 90-80 mcg inhalers (10.7 grams) on August 8, 2025, with a ceiling value of $1,864.93 and a completion date of August 11, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,023.20 delivery order on September 16, 2025, for Airsupra 90-80 mcg inhaler 10.7gm pharmaceutical supplies to support federal medical procurement needs. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 17, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,376.37 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical product. This competitively awarded, firm fixed price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of AIRSUPRA 90-80 MCG Inhaler 10.7GM with a ceiling value of $1,315.45. This delivery order is issued under a firm fixed price contract with no set-aside designation, reflecting a competitively awarded procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract has an ultimate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,651.26 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG inhaler 10.7GM pharmaceutical products. This non-set-aside contract was awarded competitively on September 19, 2025, with an ultimate completion date of September 22, 2025. The contract employs firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under...
- SPE2DB25D2207Indefinite Delivery Contract
- SPE2DB25D2207-SPE2DB25FQRAGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Airsupra 90-80 microgram inhaler units (10.7 grams) with a ceiling value of $3,128.89. This competitive award utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation and is scheduled for ultimate completion by June 5, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order exemplifies the company's role as a pharmaceutical prime vendor supplying medications across multiple therapeutic domains to support Department of Defense healthcare operations. The contract demonstrates AmerisourceBergen's established capability to fulfill federal medical supply requirements through its comprehensive IDC vehicle, which enables flexible delivery of pharmaceutical products and medical supplies to military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 6/4/25 |